AbbVie develops therapies in immunology, oncology, neuroscience, and eye care, building on the legacy of Humira with next-generation biologics. Its research collaborations with universities advance antibody-drug conjugates and targeted protein degradation.
R&D SPEND
$8.0B
INDUSTRY
Biopharma
340
ACADEMIC COLLABORATIONS
22000
PATENTS
TRY IT
Install the CLI and run your first search in under a minute. No account required to explore.
npx sci-buy@latest COPIED